ROBERT DICKINSON: Open Payments
NPI 1447851076 · SAINT AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 44 payments from 13 companies in 2025. Trend: 2023 $727 · 2024 $804 · 2025 $1,083
Food & beverage: $1,071Education: $12
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $308 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $106 |
| Braeburn Inc. | 4 | $100 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Lundbeck LLC | 2 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $54 |
| ABBVIE INC. | 3 | $52 |
| Corium, LLC | 2 | $46 |
Products named: FANAPT, REXULTI, CAPLYTA, BRIXADI, Auvelity, Jornay PM, UZEDY, VRAYLAR.
Industry payments across FL — which companies pay providers there.
